IPO registrations (S-1, F-1) · Registrants

APPLIED GENETIC TECHNOLOGIES CORP

SEC CIK
1273636 · filings on EDGAR ↗
Registration
Form S-1, first filed 2014-01-10, last 2020-02-05; 3 initial registrations, 4 amendments
Outcome
Final prospectus filed 2014-03-27; declared effective 2014-03-26
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
14193 NW 119TH TERRACE, SUITE #10, Alachua, FL 32615
EIN
59-3553710
EDGAR entity type
operating
Insiders and CEO pay
APPLIED GENETIC TECHNOLOGIES CORP on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2014-03-12)
Final price
$12.00 per share, below the range (424B4 filed 2014-03-27, an initial public offering)
Shares sold
4,166,667
Gross proceeds
$50,000,004 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol AGTC
Lead underwriters
BMO Capital Markets; Wedbush Securities
Syndicate
Cantor Fitzgerald; Roth Capital Partners

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 16

FiledFormWhat it isName as filedEDGAR
2014-01-10S-1S-1 (registration)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-008046 ↗
2014-03-04S-1/AS-1/A (amendment)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-082527 ↗
2014-03-12S-1/AS-1/A (amendment)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-094588 ↗
2014-03-26EFFECTEFFECT (declared effective)APPLIED GENETIC TECHNOLOGIES CORP9999999995-14-000777 ↗
2014-03-27424B4424B4 (final prospectus)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-118834 ↗
2014-07-11S-1S-1 (registration)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-266668 ↗
2014-07-21S-1/AS-1/A (amendment)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-273802 ↗
2014-07-24EFFECTEFFECT (declared effective)APPLIED GENETIC TECHNOLOGIES CORP9999999995-14-002232 ↗
2014-07-25424B4424B4 (final prospectus)APPLIED GENETIC TECHNOLOGIES CORP0001193125-14-280358 ↗
2015-05-20EFFECTEFFECT (declared effective)APPLIED GENETIC TECHNOLOGIES CORP9999999995-15-001415 ↗
2018-06-19EFFECTEFFECT (declared effective)APPLIED GENETIC TECHNOLOGIES CORP9999999995-18-001539 ↗
2020-01-29S-1S-1 (registration)APPLIED GENETIC TECHNOLOGIES CORP0001193125-20-018614 ↗
2020-02-05S-1/AS-1/A (amendment)APPLIED GENETIC TECHNOLOGIES CORP0001193125-20-025421 ↗
2020-02-06EFFECTEFFECT (declared effective)APPLIED GENETIC TECHNOLOGIES CORP9999999995-20-000282 ↗
2020-02-07424B4424B4 (final prospectus)APPLIED GENETIC TECHNOLOGIES CORP0001193125-20-028177 ↗
2021-04-12EFFECTEFFECT (declared effective)APPLIED GENETIC TECHNOLOGIES CORP9999999995-21-001401 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-03-12S-1/Aregistration statement$13.00–$15.003,571,000-Nasdaq AGTC4primary document; range, shares headline, cover names 4document ↗
2014-03-27424B4final prospectus$12.004,166,667$50,000,004Nasdaq AGTC4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Alta Partners Management VIII, LLCTenPercentOwner32014
Alta Partners VIII, L.P.TenPercentOwner32014
BULLOCK LAWRENCE EOfficerChief Financial Officer72014–2017
Carroll JillDirector,TenPercentOwner22014
CASH HARVEY BTenPercentOwner22014
CHAMPSI FARAHTenPercentOwner32014
Chulay Jeffrey D.OfficerSee Remarks; VP and Chief Medical Officer; V.P. & Chief Medical Officer122014–2016
GIANOS PHILIP TTenPercentOwner22014
GLAXOSMITHKLINE PLCOther; TenPercentOwner42014–2015
Holmes W StephenTenPercentOwner22014
HURWITZ EDWARDDirector132014–2022
INTERWEST INVESTORS Q VIII LPTenPercentOwner22014
INTERWEST INVESTORS VIII L PTenPercentOwner22014
InterWest Management Partners VIII, LLCTenPercentOwner22014
INTERWEST PARTNERS VIII LPTenPercentOwner22014
JANNEY DANIELTenPercentOwner32014
Kliman Gilbert HTenPercentOwner22014
Knop David R.OfficerDirector, Process Development32014
Koenig ScottDirector122014–2022
MedImmune Ventures, Inc.TenPercentOwner22014
Menichella Daniel LOfficerV.P. & Chief Business Officer52014–2015
NOHRA GUY PTenPercentOwner32014
ORONSKY ARNOLD LDirector; Director,TenPercentOwner62014–2017
Rosen JamesDirector; Director,TenPercentOwner132014–2022
Washer Susan B.Director,OfficerPresident and CEO; President & CEO; See Remarks172014–2022
Wu SamuelDirector,TenPercentOwner22014
Magovcevic IvanaDirector122014–2021
GUYER DAVID RDirector12014
Potter Stephen WOfficerChief Business Officer; See Remarks; VP and Chief Business Officer172015–2022
PEACOCK BRUCEDirector32015
Shearman Mark SOfficerChief Scientific Officer122015–2020
VANLENT ANNEDirector102016–2022
Goldstein Michael H.OfficerChief Medical Officer32016–2017
Ashe Andrew D.OfficerGeneral Counsel22017
Sullivan William A.OfficerChief Financial Officer62017–2020
Feinsod MatthewOfficerExec. VP, Global Strat. & Dev.; Interim Chief Medical Officer292017–2019
Aliski WilliamDirector82018–2022
Krex BrianDirector,Officer; OfficerGeneral Counsel42019
Heah TheresaOfficerChief Medical Officer22019
Inspirational Visions B.V.TenPercentOwner32019
Krol Patrick Johan HendrikTenPercentOwner32019
Privium Fund Management B.V.TenPercentOwner32019
Stichting Aescap 2.0TenPercentOwner32019
Reynolds Gerald AnthonyOfficerChief Accounting Officer52021–2022
Hashad YehiaDirector42021–2022
Lieber Jonathan IOfficerChief Financial Officer42021–2022
Schneider SusanOfficerChief Medical Officer42021–2022
Robinson James A. Jr.Director32021–2022
Scaria AbrahamOfficerChief Scientific Officer42021–2022
DOyley-Gay HopeOfficerGeneral Counsel42021–2022

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationAPPLIED GENETIC TECHNOLOGIES CORPORATIONFLState business registriesname and state
Plan sponsorBEACON THERAPEUTICS (USA), INC.MAForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientAPPLIED GENETIC TECHNOLOGIES CORPORATIONFLFederal spending (USAspending)name and state
Patent assigneeApplied Genetic Technologies CorporationFLPatents (USPTO)name and state
SEC filerAPPLIED GENETIC TECHNOLOGIES CORPSEC filers (EDGAR)CIK (EXACT)
Trademark ownerApplied Genetic Technologies CorporationFLTrademarks (USPTO)name and state
Business registrationBEACON THERAPEUTICS (USA), INC.State business registriesEIN (EXACT, as the state registration reports it)
Form 5500 plan sponsorBEACON THERAPEUTICS (USA), INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.